Clinical Trial Update: Rituximab in Membranous Nephropathy [Phase 2, Phase 3]

View source ↗

Summary

Rituximab was studied in Phase 2 and Phase 3 trials for membranous nephropathy, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Mayo Clinic | Conditions: Membranous Nephropathy | Phase 2, Phase 3 | Status: COMPLETED